Alimera Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alimera Sciences

14/05/2024 15:32

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -71 cents.  The mean expectation of
four analysts for the quarter was for a loss of 6 cents per
share. Wall Street expected results to range from -7 cents to -4
cents per share.
    * Revenue rose 69.9% to $23.01 million from a year ago;
analysts
expected $22.25 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The company reported a quarterly loss of $6.25 million.
    * Alimera Sciences Inc shares had fallen by 10.8% this
quarter and
lost 19.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 126.7% in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Alimera Sciences
Inc is $8.00 
This summary was machine generated from LSEG data May 14 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.06          -0.12          Missed
 Dec. 31 2023      0.00           -0.07          Missed
 Sep. 30 2023      -0.06          -0.06          Met
 Jun. 30 2023      0.02           -1.32          Missed